Pharmacokinetics of aztreonam in patients with various degrees of renal dysfunction
about
Penetration of aztreonam into cerebrospinal fluid and brain of noninfected rabbits and rabbits with experimental meningitis caused by Pseudomonas aeruginosaEvaluation of a novel method to estimate absolute bioavailability of drugs from oral data.The effect of chronic renal failure on hepatic drug metabolism and drug disposition.Pharmacokinetics of aztreonam in elderly male volunteersPharmacokinetics of aztreonam in patients with gram-negative infections.Penetration of aztreonam into cerebrospinal fluid of patients with and without inflamed meninges.Evaluation of aztreonam in the treatment of severe bacterial infections.Aztreonam in the treatment of severe urinary tract infections in pediatric patients.Evaluation of Pharmacodynamic Interactions Between Telavancin and Aztreonam or Piperacillin/Tazobactam Against Pseudomonas aeruginosa, Escherichia coli and Methicillin-Resistant Staphylococcus aureus.Continuous-infusion beta-lactam antibiotics during continuous venovenous hemofiltration for the treatment of resistant gram-negative bacteria.Pharmacokinetics and pharmacodynamics of antibacterial and antifungal agents in adult patients with thermal injury: a review of current literature.A review of the pharmacokinetics and pharmacodynamics of aztreonam.Treatment of gram-negative infections in patients with renal impairment: new alternatives to aminoglycosides.Pharmacokinetics and plasma bactericidal activity of aztreonam in low-birth-weight infants.Interspecies scaling of excretory amounts using allometry - retrospective analysis with rifapentine, aztreonam, carumonam, pefloxacin, miloxacin, trovafloxacin, doripenem, imipenem, cefozopran, ceftazidime, linezolid for urinary excretion and rifapeEvaluation of Aztreonam Dosing Regimens in Patients With Normal and Impaired Renal Function: A Population Pharmacokinetic Modeling and Monte Carlo Simulation Analysis.
P2860
Q30451285-D97641D4-09BE-4E0E-9B15-186CCEB69CF8Q30760138-90E7540C-B2B0-4435-8152-C7DAD28CE5A4Q31126303-C243B6CF-C539-41B9-A291-F4C4419D5F90Q34622283-DA88A989-3224-476C-BA31-8FCAE180F8C2Q35568767-83BA6BD3-5A6D-4F45-802F-C01DC4E51B90Q35640619-77D94806-A292-4434-86A1-C988D6FB9F1FQ35646167-2EBAC0E3-C97B-4372-B4A6-05D0A14C1334Q35651669-DDA7207E-3CF6-456F-AA35-23308BF219A9Q37250189-47C18BDB-5CF3-41AF-BE35-5063C12E398DQ37543906-95E7FFCD-F3A3-4C02-B0FD-4A6731000C63Q38244221-3AEFB53F-9B5E-4AC2-8846-6662F0BBCBE8Q38873850-6E1A6FA5-7AB2-4651-9AB7-3980243A8028Q39558431-9EE1FF25-AF16-402A-AAAF-D350D8884B08Q39827478-CAB9331D-2B82-4C03-AD28-32520F00B502Q40164668-910053E1-2763-480C-A34D-22B626A2DC53Q40573594-56D2409A-7327-4BE4-ABD7-3F956FE15AAC
P2860
Pharmacokinetics of aztreonam in patients with various degrees of renal dysfunction
description
1983 nî lūn-bûn
@nan
1983 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1983 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
name
Pharmacokinetics of aztreonam in patients with various degrees of renal dysfunction
@ast
Pharmacokinetics of aztreonam in patients with various degrees of renal dysfunction
@en
type
label
Pharmacokinetics of aztreonam in patients with various degrees of renal dysfunction
@ast
Pharmacokinetics of aztreonam in patients with various degrees of renal dysfunction
@en
prefLabel
Pharmacokinetics of aztreonam in patients with various degrees of renal dysfunction
@ast
Pharmacokinetics of aztreonam in patients with various degrees of renal dysfunction
@en
P2093
P2860
P356
P1476
Pharmacokinetics of aztreonam in patients with various degrees of renal dysfunction
@en
P2093
D A Spyker
J C Mihindu
N D Bolton
W K Bolton
W M Scheld
P2860
P304
P356
10.1128/AAC.24.2.252
P407
P577
1983-08-01T00:00:00Z